ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Chemical firms are reporting much-improved third-quarter earnings compared with the same period in 2005; 10 of the 11 firms that have published their results show double-digit or better growth.
The largest earnings growth generally came at the smaller companies. Of the five firms with less than $1 billion in quarterly sales, earnings growth ranged from 25.4% at Cytec Industries to 130.8% at Albemarle. Increases in earnings at the six larger companies were between 8.8% at PPG Industries and 35.7% at DuPont.
Albemarle posted a triple-digit improvement in earnings from continuing operations, excluding significant one-time items, of $60.7 million, on a 20% increase in sales to $608 million. "All three of our segments saw continued revenue growth and improved profitability, with both catalysts and polymer additives achieving segment income margins above our 15% corporate goal," says CEO Mark C. Rohr.
The second-largest quarterly earnings increase came at Hercules, although it also was the only company in the group to post a decline in sales. Hercules' earnings were up 66.3% to $40.9 million, while sales slipped 1.3% to $513 million. Excluding the impact of the sale of a majority stake in its FiberVisions unit, though, Hercules' sales increased 14%.
H.B. Fuller, the second-smallest company of the 11, had the third-largest earnings increase, 56.1% to $24.2 million, as sales rose 8.6% to $389 million. Fuller attributes the improvement to a more profitable mix of businesses combined with continued process improvements and productivity gains.
DuPont's strong 35.7% earnings growth to $452 million came as sales increased just 7.5% to $6.31 billion. The company notes that raw material costs were $180 million higher than in the third quarter last year but were fully offset by increases in selling price.
Industry leader Dow Chemical posted earnings of $950 million, up 18.6% from third-quarter 2005, on a 9.8% increase in sales to $12.4 billion. Geoffrey E. Merszei, Dow's chief financial officer says, "This was an excellent quarter: solid price increases across virtually every business and in every geographic region, encouraging volume growth in our performance segments, operating rates that were the highest since first-quarter 2005, and record equity earnings."
While reporting earnings, Dow also announced a share repurchase program of up to $2 billion to take effect once its current repurchase plan is concluded. CEO Andrew N. Liveris says, "Our solid financial position allows us to undertake this program while retaining the financial flexibility necessary to invest in our growth strategy, whether through new capital projects or by pursuing appropriate merger and acquisition opportunities."
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X